Ultrastructure and histomorphometric analysis of human umbilical cord vessels in preeclampsia: a potential role of VEGF, VEGFR-1 and VEGFR-2

被引:0
|
作者
Almasry, Shaima M. [1 ,2 ]
Elfayomy, Amr K. [3 ,4 ]
Hashem, Hala E. [5 ]
机构
[1] Taibah Univ, Dept Anat, Al Madinah Al Munawarah, Saudi Arabia
[2] Almansoura Univ, Dept Anat & Embryol, Mansoura, Egypt
[3] Taibah Univ, Dept Obstet & Gynecol, Al Madinah Al Munawarah, Saudi Arabia
[4] Zagazig Univ, Dept Obstet & Gynecol, Zagazig, Egypt
[5] Zagazig Univ, Dept Histol & Cell Biol, Zagazig, Egypt
关键词
VEGF; VEGFR-1; VEGFR-2; umbilical cord vessels; ENDOTHELIAL GROWTH-FACTOR; MUSCLE-CELL PROLIFERATION; FACTOR RECEPTOR-1; VASCULAR-PERMEABILITY; EXPRESSION; ARTERIAL; HYPOXIA; MOUSE;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aim: This study aimed to analyze the ultrastructure and histomorphometric changes of the human umbilical cord vessels of preeclampsia compared to healthy pregnancies and the possible role of vascular endothelial growth factor (VEGF) and its receptors. Materials and Methods: Umbilical cord (UC) specimens were collected between August, 2014 and July, 2015. Histomorphometric analysis of UC vessels was performed utilizing an image analysis system. Cellular localization of VEGF, VEGFR-1 (VEGF receptor-1) and VEGFR-2 (VEGF receptor-2) were examined in immunohistochemically-stained sections of UC from 45 pregnancies with preeclampsia (PE) and 40 healthy pregnancies. Results: Compared with healthy pregnancies, UC venous measurements were significantly higher in PE; total venous area (p<0.001), lumina] venous area (p<0.001) and luminal venous index (p=0.005). Arterial measurements except for the total arterial area were significantly lower in the PE compared to healthy pregnancies, luminal arterial area (p=0.32) and luminal arterial index (p=0.004). Histological and ultrastructural examination of UC from PE revealed discontinuity of vascular endothelium and disorganized edematous widely spaced smooth muscle cells. We demonstrated a significant increase in tissue expression of VEGF in PE (16.6 +/- 0.1) compared to healthy pregnancies (12 +/- 0.8) (p=0.001). Also, significant higher VEGFR-1 expression in PE (20.5 +/- 2.5) compared to healthy pregnancies (9.5 +/- 1.2) (p<0.001) has been observed. However, tissue expression of VEGFR-2 was decreased significantly in PE (10.5 +/- 0.7) compared to healthy pregnancies (13.8 +/- 1.6) (p=0.043). Conclusions: Altered tissue expression of VEGF and its receptors in the UC vessels could play a crucial role in disturbing the UC vascular endothelium, smooth muscles and measurements and this may underlie the existence of preeclampsia.
引用
收藏
页码:681 / 689
页数:9
相关论文
共 50 条
  • [31] Mechanism of the HIF-1α/VEGF/VEGFR-2 pathway in the proliferation and apoptosis of human haemangioma endothelial cells
    Zhang, Wenpei
    Sun, Lei
    Gao, Hongxia
    Wang, Shengquan
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2023, 104 (05) : 258 - 268
  • [32] 下肢慢性缺血患者的超重和肥胖对血浆中VEGF-A、VEGFR-1和VEGFR-2浓度的影响(英文)
    Radosaw WIECZR
    Anna Maria WIECZR
    Grayna GADOMSKA
    Katarzyna STANKOWSKA
    Jacek FABISIAK
    Karol SUPPAN
    Grzegorz PULKOWSKI
    Jacek BUDZYSKI
    Danuta RO
    Journal of Zhejiang University-Science B(Biomedicine & Biotechnology), 2016, 17 (11) : 842 - 849
  • [33] 下肢慢性缺血患者的超重和肥胖对血浆中VEGF-A、VEGFR-1和VEGFR-2浓度的影响(英文)
    Rados?aw WIECZóR
    Anna Maria WIECZóR
    Gra?yna GADOMSKA
    Katarzyna STANKOWSKA
    Jacek FABISIAK
    Karol SUPPAN
    Grzegorz PULKOWSKI
    Jacek BUDZY?SKI
    Danuta RO??
    Journal of Zhejiang University-Science B(Biomedicine & Biotechnology), 2016, (11) : 842 - 849
  • [34] Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3
    Tanno, S
    Ohsaki, Y
    Nakanishi, K
    Toyoshima, E
    Kikuchi, K
    LUNG CANCER, 2004, 46 (01) : 11 - 19
  • [35] Microvascular density and immunohistochemical expression of VEGF, VEGFR-1 and VEGFR-2 in benign prostatic hyperplasia, high-grade prostate intraepithelial neoplasia and prostate cancer
    Grivas, Nikolaos
    Goussia, Anna
    Stefanou, Dimitrios
    Giannakis, Dimitrios
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2016, 69 (01) : 63 - 71
  • [36] VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody
    Micheli, Laura
    Parisio, Carmen
    Lucarini, Elena
    Vona, Alessia
    Toti, Alessandra
    Pacini, Alessandra
    Mello, Tommaso
    Boccella, Serena
    Ricciardi, Flavia
    Maione, Sabatino
    Graziani, Grazia
    Lacal, Pedro Miguel
    Failli, Paola
    Ghelardini, Carla
    Di Cesare Mannelli, Lorenzo
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [37] Association of plasma VEGF-A, soluble VEGFR-1 and VEGFR-2 levels and clinical response and survival in advanced colorectal cancer patients receiving bevacizumab with modified FOLFOX6
    Aoyagi, Yoshiko
    Iinuma, Hisae
    Horiuchi, Atsushi
    Shimada, Ryu
    Watanabe, Toshiaki
    ONCOLOGY LETTERS, 2010, 1 (02) : 253 - 259
  • [38] Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients
    Ustuner, Zeki
    Saip, Pinar
    Yasasever, Vildan
    Vural, Burcak
    Yazar, Aziz
    Bal, Cengiz
    Ozturk, Betul
    Ozbek, Ugur
    Topuz, Erkan
    MEDICAL ONCOLOGY, 2008, 25 (04) : 394 - 399
  • [39] Ranibizumab interacts with the VEGF-A/VEGFR-2 signaling pathway in human RPE cells at different levels
    Ranjbar, Mahdy
    Brinkmann, Max Philipp
    Tura, Ayseguel
    Rudolf, Martin
    Miura, Yoko
    Grisanti, Salvatore
    CYTOKINE, 2016, 83 : 210 - 216
  • [40] VEGFR-1、VEGFR-2和HGF表达情况与乙肝发病相关性及作用机制分析
    刘圆方
    樊宏伟
    高改云
    倪猛
    李静
    实验与检验医学, 2018, 36 (02) : 168 - 170+177